TWEAK activates the non-canonical NFκB pathway in murine renal tubular cells: Modulation of CCL21

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Sanz, Ana B ^c   Sanchez Niño, Maria D ^a   Izquierdo, Maria C ^a   Jakubowski, Aniela ^b   Justo, Pilar ^a   Blanco Colio, Luis M ^a   Ruiz Ortega, Marta ^a   Selgas, Rafael ^c   Egido, Jesús ^a   Ortiz, Alberto ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b BIOGEN   (United States)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE TWEAK; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P100; PROTEIN P52; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DNA BINDING; KIDNEY INJURY; KIDNEY TUBULE CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; CELLS, CULTURED; CHEMOKINE CCL21; ENZYME-LINKED IMMUNOSORBENT ASSAY; KIDNEY TUBULES; MICE; MICROSCOPY, CONFOCAL; NF-KAPPA B; TUMOR NECROSIS FACTORS;

MURINAE;

EID: 77749282951     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008955     Document Type: Article

References (44)

1. Remuzzi G, Ruggenenti P, Benigni A (1997) Understanding the nature of renal disease progression. Kidney Int 51: 2-15.
2. van Kooten C, Daha MR, van Es LA (1999) Tubular epithelial cells: A critical cell type in the regulation of renal inflammatory processes. Exp Nephrol 7: 429-437.
3. de Haij S, Daha MR, van KC (2004) Mechanism of steroid action in renal epithelial cells. Kidney Int 65: 1577-1588.
4. Locksley RM, Killeen N, Lenardo MJ (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104: 487-501.
5. Justo P, Sanz A, Lorz C, Gomez-Garre D, Mezzano S, Egido J, et al. (2003) Expression of Smac/Diablo in tubular epithelial cells and during acute renal failure. Kidney Int Suppl: S52-S56.
6. Lorz C, Ortiz A, Justo P, Gonzalez-Cuadrado S, Duque N, et al. (2000) Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. J Am Soc Nephrol 11: 1266-1277.
7. Boonstra JG, van der Woude FJ, Wever PC, Laterveer JC, Daha MR, et al. (1997) Expression and function of Fas (CD95) on human renal tubular epithelial cells. J Am Soc Nephrol 8: 1517-1524.
8. Navarro JF, Mora-Fernandez C (2006) The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications. Cytokine Growth Factor Rev 17: 441-450.
9. Sanz AB, Justo P, Sanchez-Nino MD, Blanco-Colio LM, Winkles JA, et al. (2008) The Cytokine TWEAK Modulates Renal Tubulointerstitial Inflammation. J Am Soc Nephrol 19: 695-703.
10. Justo P, Sanz AB, Sanchez-Nino MD, Winkles JA, Lorz C, et al. (2006) Cytokine cooperation in renal tubular cell injury: the role of TWEAK. Kidney Int 70: 1750-1758.
11. Campbell S, Burkly LC, Gao HX, Berman JW, Su L, et al. (2006) Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells. J Immunol 176: 1889-1898.
12. Carragher D, Johal R, Button A, White A, Eliopoulos A, et al. (2004) A stromaderived defect in NF-kappaB22/2 mice causes impaired lymph node development and lymphocyte recruitment. J Immunol 173: 2271-2279.
13. Zhao Z, Burkly LC, Campbell S, Schwartz N, Molano A, et al. (2007) TWEAK/ Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus. J Immunol 179: 7949-7958.
14. Campbell S, Michaelson J, Burkly L, Putterman C (2004) The role of TWEAK/ Fn14 in the pathogenesis of inflammation and systemic autoimmunity. Front Biosci 9: 2273-2284.
15. Harada N, Nakayama M, Nakano H, Fukuchi Y, Yagita H, et al. (2002) Proinflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells. Biochem Biophys Res Commun 299: 488-493.
16. Chicheportiche Y, Chicheportiche R, Sizing I, Thompson J, Benjamin CB, et al. (2002) Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies. Arthritis Res 4: 126-133.
17. Tran NL, McDonough WS, Savitch BA, Sawyer TF, Winkles JA, et al. (2005) The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression. J Biol Chem 280: 3483-3492.
18. Dejardin E (2006) The alternative NF-kappaB pathway from biochemistry to biology. Biochem Pharmacol 72: 1161-1179.
19. Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, et al. (2002) The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17: 525-535.
20. Claudio E, Brown K, Park S, Wang H, Siebenlist U (2002) BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol 3: 958-965.
21. Kayagaki N, Yan M, Seshasayee D, Wang H, Lee W, et al. (2002) BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity 17: 515-524.
22. Coope HJ, Atkinson PG, Huhse B, Belich M, Janzen J, et al. (2002) CD40 regulates the processing of NF-kappaB2 p100 to p52. EMBO J 21: 5375-5385.
23. Novack DV, Yin L, Hagen-Stapleton A, Schreiber RD, Goeddel DV, et al. (2003) The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis. J Exp Med 198: 771-781.
24. Saitoh T, Nakayama M, Nakano H, Yagita H, Yamamoto N, et al. (2003) TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation. J Biol Chem 278: 36005-36012.
25. Cuenca J, Goren N, Prieto P, Martin-Sanz P, Bosca L (2007) Selective impairment of nuclear factor-kappaB-dependent gene transcription in adult cardiomyocytes: relevance for the regulation of the inflammatory response in the heart. Am J Pathol 171: 820-828.
26. Sakai N, Wada T, Yokoyama H, Lipp M, Ueha S, et al. (2006) Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci U S A 103: 14098-14103.
27. Ortiz A, Lorz C, Catalan MP, Danoff TM, Yamasaki Y, et al. (2000) Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure. Kidney Int 57: 969-981.
28. Ortega A, Ramila D, Ardura JA, Esteban V, Ruiz-Ortega M, et al. (2006) Role of parathyroid hormone-related protein in tubulointerstitial apoptosis and fibrosis after folic acid-induced nephrotoxicity. J Am Soc Nephrol 17: 1594-1603.
29. Fang TC, Alison MR, Cook HT, Jeffery R, Wright NA, et al. (2005) Proliferation of bone marrow-derived cells contributes to regeneration after folic acid-induced acute tubular injury. J Am Soc Nephrol 16: 1723-1732.
30. Doi K, Okamoto K, Negishi K, Suzuki Y, Nakao A, et al. (2006) Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice. Am J Pathol 168: 1413-1424.
31. Nemeth ZH, Wong HR, Odoms K, Deitch EA, Szabo C, et al. (2004) Proteasome inhibitors induce inhibitory kappa B (I kappa B) kinase activation, I kappa B alpha degradation, and nuclear factor kappa B activation in HT-29 cells. Mol Pharmacol 65: 342-349.
32. Hehner SP, Hofmann TG, Droge W, Schmitz ML (1999) The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex. J Immunol 163: 5617-5623.
33. Lo JC, Chin RK, Lee Y, Kang HS, Wang Y, et al. (2003) Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues. J Clin Invest 112: 1495-1505.
34. Chen SC, Vassileva G, Kinsley D, Holzmann S, Manfra D, et al. (2002) Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J Immunol 168: 1001-1008.
35. Bonizzi G, Bebien M, Otero DC, Johnson-Vroom KE, Cao Y, et al. (2004) Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. EMBO J 23: 4202-4210.
36. Hoffmann A, Levchenko A, Scott ML, Baltimore D (2002) The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298: 1241-1245.
37. Sanz AB, Sanchez-Nino MD, Izquierdo MC, Jakubowski A, Justo P, et al. (2009) TWEAK Induces proliferation in renal tubular epithelium: a role in uninephrectomy-induced renal hyperplasia. J Cell Mol Med, 2009 May 1 [Epub ahead of print].
38. Gao HX, Campbell SR, Burkly LC, Jakubowski A, Jarchum I, et al. (2009) TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells. Cytokine Growth Factor Rev 20: 251-8.
39. Sanchez-Sanchez N, Riol-Blanco L, Rodriguez-Fernandez JL (2006) The multiple personalities of the chemokine receptor CCR7 in dendritic cells. J Immunol 176: 5153-5159.
40. Banas B, Wornle M, Berger T, Nelson PJ, Cohen CD, et al. (2002) Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis. J Immunol 168: 4301-4307.
41. Kerjaschki D, Regele HM, Moosberger I, Nagy-Bojarski K, Watschinger B, et al. (2004) Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 15: 603-612.
42. Morrissey JJ, Klahr S (1997) Rapid communication. Enalapril decreases nuclear factor kappa B activation in the kidney with ureteral obstruction. Kidney Int 52: 926-933.
43. Loverre A, Ditonno P, Crovace A, Gesualdo L, Ranieri E, et al. (2004) Ischemiareperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin. J Am Soc Nephrol 15: 2675-2686.
44. Starkey JM, Haidacher SJ, LeJeune WS, Zhang X, Tieu BC, et al. (2006) Diabetes-induced activation of canonical and noncanonical nuclear factorkappaB pathways in renal cortex. Diabetes 55: 1252-1259.